Seattle Genetics

Seattle Genetics Is Growing Up Any Way It Can
Motley Fool
Thu, 02/8/18 - 11:48 pm
Seattle Genetics
Pharma M&A machine unstoppable: Seattle Genetics acquires Cascadian for $614m
GoinPharma
Wed, 01/31/18 - 11:15 am
Seattle Genetics
M&A
Cascadian
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Yahoo/Zacks.com
Fri, 01/5/18 - 05:33 pm
cancer
Merck
Japan
Keytruda
Seattle Genetics
Adcetris
Novartis
Kisqali
ASH: Seattle Genetics CEO sees a big new Adcetris market, but one analyst has some doubts
Fierce Pharma
Mon, 12/11/17 - 11:35 am
ASH17
Seattle Genetics
Adcetris
Hodgkin's lymphoma
ASH17: Seattle Genetics sees market opportunity in cancer combo success
BioPharma Dive
Sun, 12/10/17 - 09:59 am
ASH17
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion
Yahoo/Zacks.com
Mon, 11/13/17 - 10:39 am
Seattle Genetics
Adcetris
FDA
primary cutaneous anaplastic large cell lymphoma
Inching closer to blockbuster status, Seattle Genetics gets fourth FDA win for Adcetris
Endpoints
Fri, 11/10/17 - 11:26 am
Seattle Genetics
FDA
Adcetris
cutaneous T-cell lymphoma
Seven years in the making, Seattle Genetics picks up early option on Genmab’s ADC effort
Endpoints
Tue, 08/29/17 - 09:36 am
Seattle Genetics
Genmab
antibody-drug conjugate
tisotumab vedotin
Seattle Genetics Drug Scratches Out Win In Hodgkin Lymphoma
Forbes
Mon, 06/26/17 - 10:23 am
Seattle Genetics
Takeda
Hodgkin's lymphoma
Adcetris
What we know from BIO2017
BioPharma Dive
Fri, 06/23/17 - 11:30 am
BIO2017
M&A
Novartis
Novo Nordisk
Seattle Genetics
ImmunoCellular Therapeutics
FDA padlocks any new human tests on Seattle Genetics’ cancer drug in the wake of more deaths
Endpoints
Thu, 06/22/17 - 09:38 am
FDA
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’
Seattle Times, WA
Mon, 06/19/17 - 11:38 pm
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Bristol-Myers and Seattle Genetics move a promising flagship combo into PhIII
Endpoints
Fri, 06/2/17 - 11:16 am
Bristol-Myers
Seattle Genetics
Opdivo
Adcetris
Hodgkin's lymphoma
Seattle Genetics reports 1Q loss
Yahoo/AP
Thu, 04/27/17 - 05:54 pm
Seattle Genetics
earnings
Seattle Genetics resumes two leukemia trials, ends one after FDA lifts hold
Bizjournals.com
Wed, 03/8/17 - 09:50 am
Seattle Genetics
clinical trials
FDA
vadastuximab talirine
Seattle Genetics to resume trials as FDA lifts clinical hold
Yahoo/Reuters
Mon, 03/6/17 - 09:52 am
Seattle Genetics
clinical trials
FDA
vadastuximab talirine
AML
acute myeloid leukemia
Will Seattle Genetics' Deal With Immunomedics Get Scuttled?
Motley Fool
Mon, 02/13/17 - 10:02 am
Seattle Genetics
Immunomedics
IMMU-132
Immunomedics, Seattle Genetics Lead Biotech Movers on Deal News
TheStreet.com
Fri, 02/10/17 - 09:52 am
Immunomedics
Seattle Genetics
M&A
solid tumors
Adcetris
Seattle Genetics reports 4Q loss
Yahoo/AP
Fri, 02/10/17 - 09:50 am
Seattle Genetics
earnings
Biotech Stocks: What to Watch in 2017
Motley Fool
Sun, 01/1/17 - 11:33 am
biotech
Seattle Genetics
Exelixis
Clovis Oncology
Kite Pharma

Pages